| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 13, 2019 | 197.90 | 204.16 | 193.51 | 195.00 | 54,798 |
| Sep 12, 2019 | 190.00 | 198.00 | 185.00 | 195.00 | 81,165 |
| Sep 11, 2019 | 192.49 | 194.89 | 185.00 | 190.00 | 102,425 |
| Sep 10, 2019 | 195.00 | 204.00 | 185.50 | 195.00 | 367,992 |
| Sep 9, 2019 | 203.49 | 211.90 | 196.51 | 200.00 | 171,738 |
| Name | ReNeuron Group | Epic | RENE |
|---|---|---|---|
| ISIN | GB00BF5G6K95 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 3,000 | Prev Close | 195.00 |
| Shares in Issue (m) | 31.83 | Market Cap (£m) | 62.07 |
| PE Ratio | -4.31 | Div per Share () | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -45.20 | EPS Growth (%) | 18.85 |
| PEG | -0.23 | DPS Growth (%) | n/a |
| ROCE | -73.36 | Net Gearing | -42.15 |
| Quick Ratio | 4.04 | Current Ratio | 4.04 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 09 Nov | Stifel | Buy | 203.50 | 13.00 | 13.00 | Reiterates |
| 29 Jun | N+1 Singer | Buy | 203.50 | - | - | Reiterates |
| 27 Apr | N+1 Singer | Buy | 203.50 | 9.00 | 9.00 | Reiterates |
| 04 Apr | Stifel | Buy | 203.50 | 15.00 | 15.00 | Reiterates |
| 04 Jan | N+1 Singer | Buy | 203.50 | 9.00 | 9.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 18 Apr 2019 | Prof Sir Chris Evans | Buy | 10,000 @ 228.70p | £22,870.00 |
| 11 Apr 2019 | John Berriman | Buy | 80,000 @ 225.00p | £180,000.00 |
| 11 Apr 2019 | Simon Cartmell | Buy | 7,758 @ 225.55p | £17,498.17 |
| 11 Apr 2019 | Prof Sir Chris Evans | Buy | 4,500 @ 221.50p | £9,967.50 |
| 11 Apr 2019 | Dr Mike Owen | Buy | 4,237 @ 236.00p | £9,999.32 |
